Ashland expands R&D centre

Ashland plans to expand its formulation development and GMP contract manufacturing services for solid dispersions and oral solid dosages at its pharmaceutical R&D centre in Wilmington, DE. The expansion, which aims to support early-stage clinical trials, will include spray drying and extrusion processes previously located in Columbia, MD. Ashland said it wool relocate approximately 20 positions from Columbia to Wilmington as a result of the expansion, which is expected to be operational by summer 2014.
Manufacturing Chemist